new Glioblastoma treatment attacks brain tumors from multiple angles
On Nov. 12, 2024, researchers from the University of Basel and University Hospital Basel announced they had developed…
Swissmedic Authorises CSL’s HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia B
On Jan. 15, 2024, CSL announced that Swissmedic had authorised HEMGENIX® (etranacogene dezaparvovec), the first and currently only gene…
Novavax files for conditional Marketing Authorization of COVID-19 vaccine in Switzerland
On Feb. 14, 2022, Novavax announced its submission to Swissmedic, the Swiss Agency for Therapeutic Products, for conditional…
A live, oral typhoid vaccine (Ty21a, Vivotif Berna by Swiss Serum Institute) was licensed
On Dec. 15, 1989, the live, oral typhoid vaccine (Ty21a, Vivotif Berna by Swiss Serum Institute) was licensed….